https://www.selleckchem.com/pr....oducts/Staurosporine
Background The huntingtin gene (HTT) pathogenic cytosine-adenine-guanine (CAG) repeat expansion responsible for Huntington disease (HD) is phased with single nucleotide polymorphisms (SNPs), providing targets for allele-selective treatments. Objective This prospective observational study defined the frequency at which rs362307 (SNP1) or rs362331 (SNP2) was found on the same allele with pathogenic CAG expansions. Methods Across 7 US sites, 202 individuals with HD provided blood samples that were processed centrally to determine the
Like
Comment
Share
